» Articles » PMID: 35936148

Evans Syndrome Presenting As an Atypical Complication of SARS-CoV-2 Vaccination

Overview
Journal Cureus
Date 2022 Aug 8
PMID 35936148
Authors
Affiliations
Soon will be listed here.
Abstract

The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has drastically affected our daily lives, causing millions of deaths worldwide. The early and late complications of this infection are being increasingly revealed on a regular basis; however, an important brake on the spread and especially the lethality of the disease has been guaranteed by the introduction of mRNA-based and viral vector-based COVID-19 Vaccines. Also, an increasing number of adverse effects of the vaccination have been reported to specific pharmacovigilance boards, most of them totally non-serious events that are resolved within one to three days after the administration of the vaccine. In this report, we present a case of Evans syndrome (ES) secondary to SARS-CoV-2 vaccination in an 85-year-old male patient. To the best of our knowledge, this is the first case of ES caused by the COVID-19 vaccination to be reported in the literature.

Citing Articles

Evans' syndrome following vaccination with ChAdOx1 nCoV-19 in a patient with new-onset localized scleroderma.

Gambichler T, Nordmann P, Scheel C, Susok L Dermatol Reports. 2022; 14(4):9470.

PMID: 36483231 PMC: 9724721. DOI: 10.4081/dr.2022.9470.

References
1.
Lecouffe-Desprets M, Neel A, Graveleau J, Leux C, Perrin F, Visomblain B . Venous thromboembolism related to warm autoimmune hemolytic anemia: a case-control study. Autoimmun Rev. 2015; 14(11):1023-8. DOI: 10.1016/j.autrev.2015.07.001. View

2.
Hidaka D, Ogasawara R, Sugimura S, Fujii F, Kojima K, Nagai J . New-onset Evans syndrome associated with systemic lupus erythematosus after BNT162b2 mRNA COVID-19 vaccination. Int J Hematol. 2021; 115(3):424-427. PMC: 8536917. DOI: 10.1007/s12185-021-03243-2. View

3.
Gonzalez-Nieto J, Martin-Suarez I, Quattrino S, Ortiz-Lopez E, Munoz-Beamud F, Colchero-Fernandez J . The efficacy of romiplostim in the treatment of severe thrombocytopenia associated to Evans syndrome refractory to rituximab. Lupus. 2011; 20(12):1321-3. DOI: 10.1177/0961203311404913. View

4.
Zhang Y, Zeng X, Jiao Y, Li Z, Liu Q, Ye J . Mechanisms involved in the development of thrombocytopenia in patients with COVID-19. Thromb Res. 2020; 193:110-115. PMC: 7274097. DOI: 10.1016/j.thromres.2020.06.008. View

5.
Godeau B, Chevret S, Varet B, Lefrere F, Zini J, Bassompierre F . Intravenous immunoglobulin or high-dose methylprednisolone, with or without oral prednisone, for adults with untreated severe autoimmune thrombocytopenic purpura: a randomised, multicentre trial. Lancet. 2002; 359(9300):23-9. DOI: 10.1016/S0140-6736(02)07275-6. View